🇺🇸 FDA
Patent

US 9339482

Methods to treat dysregulated blood glucose disorders

granted A61KA61K31/198A61K31/42

Quick answer

US patent 9339482 (Methods to treat dysregulated blood glucose disorders) held by Regents of the University of Minnesota expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/198, A61K31/42, A61K38/28, A61K45/06